SLN
OTC MARKETS · Biotechnology
Silence Therapeutics PLC
$11.16
-0.02 (-0.18%)
Performance
1D
—
1W
—
1M
—
3M
+6.29%
6M
+87.88%
1Y
+74.92%
YTD
+74.92%
Open$11.14
Previous Close$11.18
Day High$11.35
Day Low$11.01
52W High$5.99
52W Low$1.06
Volume—
Avg Volume2.5K
Market Cap697.37M
P/E Ratio—
EPS$-0.48
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$9.57
Above
RSI (14)
65.7
Neutral
Key Financials
| FY 2026 | |
|---|---|
| Revenue | 14.24M |
| Net Income | -30,159,021 |
| Profit Margin | -231.4% |
| EBITDA | -33,794,946 |
| Free Cash Flow | — |
| Rev Growth | +315.5% |
| Debt/Equity | 2.02 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |